Guerbet: Financial agenda for 2024
16 January 2024 - 4:00AM
Guerbet: Financial agenda for 2024
Financial agenda for 2024
Villepinte,
15 January 2024: Guerbet (FR0000032526),
a global specialist in contrast agents and solutions for medical
imaging, is announcing its financial agenda for 2024.
|
Publications calendar |
|
February 08, 2024, after trading |
|
March 20, 2024, after trading |
|
April 25, 2024, after trading |
- ANNUAL SHAREHOLDERS’ MEETING
May 24, 2024 |
|
July 25, 2024, after trading |
|
September 25, 2024, after trading |
|
October 24, 2024, after trading |
About
Guerbet
At Guerbet, we build
lasting relationships so that we enable people to live better. That
is our purpose. We are a leader in medical imaging worldwide,
offering a comprehensive range of pharmaceutical products, medical
devices, and digital and AI solutions for diagnostic and
interventional imaging. A pioneer in contrast media for 95 years,
with more than 2,600 employees worldwide, we continuously innovate
and devote 10% of our sales to research and development in four
centres in France, Israel, and the United States. Guerbet (GBT) is
listed on Euronext Paris (segment B – mid caps) and generated €753
million in revenue in 2022.
Contacts :
Guerbet Jérôme Estampes, Chief
Financial Officer + 33.1.45.91.50.00 /
jerome.estampes@guerbet.comClaire Lauvernier, Group Communication
Director +33.6.79.52.11.88 / claire.lauvernier@guerbet.com
Actifin
Marianne Py, Financial
Communication + 33.1.80.48.25.31 / marianne.py@seitosei-actifin.com
Jennifer Jullia, Media Relations +33.1.56.88.11.19 /
jennifer.jullia@seitosei-actifin.com
Guerbet (LSE:0ELV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Guerbet (LSE:0ELV)
Historical Stock Chart
From Apr 2023 to Apr 2024
